about
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodiesLongitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative diseaseAn Introduction to Survival Statistics: Kaplan-Meier AnalysisMultiple imputation: dealing with missing data.Survival analysis of time-to-event data in respiratory health research studies.Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile dataChemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields).Effects of cortisol on the intestinal mucosal immune response during cohabitant challenge with IPNV in Atlantic salmon (Salmo salar).More patients should undergo surgery after sigmoid volvulus.Six minute walk distance is a predictor of survival in patients with chronic obstructive pulmonary disease undergoing pulmonary rehabilitationHigh revision and reoperation rates using the Agility™ Total Ankle System.Effect of different synthetic membranes on laboratory parameters and survival in chronic haemodialysis patientsDifferences in progression to ESRD between black and white patients receiving predialysis care in a universal health care system.Study on molecular mechanism of ANOS1 promoting development of colorectal cancer.Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort.Controlled and Targeted Drug Delivery by a UV-responsive Liposome for Overcoming Chemo-resistance in Non-Hodgkin Lymphoma.Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.Simultaneous surgery in patients with both cardiac and noncardiac diseases.Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis.The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method.Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.FEES protocol derived estimates of sensitivity: aspiration in dysphagic patients.Poor biosecurity could lead to disease outbreaks in animal populations.Vitamin K antagonist use and renal function in pre-dialysis patients.Dynamics of Spirochetemia and Early PCR Detection of Borrelia miyamotoi.Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index
P2860
Q24318474-6759F8FA-B5C3-4F97-9ACA-5FA8E65A84D3Q26865220-8AC5D072-A057-4CC7-888E-BA322D8741ABQ28077386-0446B0FE-5F23-4FDD-8042-5EA7AF3AE1BEQ30638883-73F5691B-0B30-433D-A4C1-BDAEF95EDD8FQ30790979-7B7F496F-A9E7-4BBD-A8DC-7298C44BE50FQ31150103-7F977A77-C76A-453E-B2F6-5C3CF34E4058Q33398646-EC88341C-8362-4A52-B4BA-7615D130F51BQ33583817-FC22298F-8679-4399-997C-6E956CCBF5DCQ34779218-65B8AE99-76C6-4BA8-8B77-D5F3E03710F7Q35934386-E9D9304C-0E8D-4E26-928F-C14D6EE2269AQ36013361-7D23F190-F1E2-4EFA-9D32-2F72FEFAB19AQ36745402-140DA2EF-C3BE-4EAE-B059-5BCCBC2FEDB5Q37246989-77B7F929-8CAB-4AFB-A497-A430E719CF34Q38602210-862CDE2D-A4BA-48B3-96DA-CEB8D438AC5DQ38671285-4ADBE47B-4D90-4E73-AF18-5CBDBFFCCB3EQ38903528-BF3FFC42-32EF-4FDC-A1C9-2D4B2BE00E97Q39607166-5C4FD550-A008-4C40-87B2-C923E95775A4Q40590211-18E46F2E-C665-40F2-B828-AD480FF0ED90Q41827284-4DF73DA4-4B8D-417F-BDC3-D7B6F7A18E38Q45905870-31995E22-3C8F-494F-A1D9-B0BE5C390454Q46854252-0A8578BD-A979-42AB-833A-5016A7D633C9Q51711609-68B40C28-4E7E-43DF-BF3D-FD472147D380Q51784270-3099707D-705C-4423-9184-41DCA99ABE0DQ54940282-72512946-1B6A-472A-9F94-78DCB6A8365CQ55078337-F717E1E4-4CDC-485A-B1D2-0D9B5167E034Q58732743-AE0F9CBD-4B0E-4272-9C54-6AABC29BDE03
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The analysis of survival data: the Kaplan-Meier method.
@en
type
label
The analysis of survival data: the Kaplan-Meier method.
@en
prefLabel
The analysis of survival data: the Kaplan-Meier method.
@en
P356
P1433
P1476
The analysis of survival data: the Kaplan-Meier method.
@en
P2093
Kitty J Jager
Paul C van Dijk
P2888
P304
P356
10.1038/KI.2008.217
P407
P577
2008-07-02T00:00:00Z
P5875
P6179
1007285082